Drug Makers Could Hike Prices Before Inflationary Rebates Kick In

By Rachel Cohrs / August 9, 2019 at 2:14 PM

The controversial inflationary rebate policy in the Senate Finance Committee’s drug-pricing package could incentivize drug makers to raise prices before the bill would take effect in 2022, sources say.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.